NCT04307134
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
- Locations
-
- Pfizer Seoul, South Korea
Clinical trial condition
Explore clinical trials studying Hematologic Malignancy. Study availability and eligibility vary by location and protocol.
NCT04307134
NCT04952766
NCT04826458
NCT07249138
NCT05238376
NCT05509439
NCT04827446
NCT03149055
NCT01341301
NCT04886622